bachelor's at Interno da 1ª Cadeira de Clínica Médica from Faculdade de Medicina da Universidade Federal do Rio de Janeiro (1969), bachelor's at Bolsista Acadêmico da Suseme from Hospital Estadual Souza Aguiar (1969), bachelor's at Estágio from Centro de Tratamento Intensivo do Hospital Souza Aguiar (1969), bachelor's at Especilização Em Imunologia from Universidade do Brasil (1964), bachelor's at Temas de Nutrição e Metabolismo from Sociedade Brasileira de Gastroenterologia e Nutrição (1966), bachelor's at Curso de Endocrinologia Ginecológica from Instituto de Ginecologia da Universidade do Brasil (1967), bachelor's at Temas de Tratamento Intensivo from Centro de Estudos Treinamento e Aperfeiçoamento do Hospital Souza Aguiar (1969), bachelor's at Medicina from Universidade Federal do Rio de Janeiro (1969) and doctorate at Endocrinology from Universidade de São Paulo (1983). Has experience in Medicine, focusing on Endocrinology, acting on the following subjects: hiperprolactinemia, prolactinomas, acromegalia, agonistas dopaminérgicos and endocrinologia e metabologia. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Prolactin-secreting pituitary tumors (PRL) (prolactinomas) are the most prelevant pituitary tumors and its first line treatment are dopaminergic agonists (DA), being effective in about 80% of cases. However, the remaining 20% partial or total resistance to these drugs require alternative treatment. PRL binds to its receptor (PRLR), a member of the cytokine receptor family and activates si…
Although pituitary tumors are usually benign, about 5-35% have invasive behavior, extending to local tissues, including the cavernous sinus, sphenoid sinus, orbit and clivus. The reasons for these differences are poorly understood and, to date, there is no effective marker capable of predicting the invasive behavior of pituitary tumors. Considering that the invasiveness is the major deter…
Ketoconazole, antifungal agent, which revealed a potent inhibitor of adrenal steroidogenesis, can be used in the management of Cushing's disease when it is not controlled by surgical procedure and/or radiotherapy. Although it was expected that, with the reduction of serum cortisol levels and urinary occurrance elevation of plasma ACTH, this fact is often not observed. A hypothesis to expl…
Acromegaly has variable clinical spectrum ranging from cases with classical symptoms associated with multiple co-morbidities to subclinical or asymptomatic. Generally, the severity of clinical manifestations does not correlate with the degree of GH/IGF-I.The laboratory is characterized by high levels of GH and IGF-I.The dose of GH during the test oral glucose tolerance (OGTT) is considere…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing research grants |
| 5 / 4 | Completed research grants |
| 2 / 0 | Completed scholarships in Brazil |
| 8 / 5 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID